Ataxia Comprehensive Panel Genetic Test in UAE | 3000 AED | DHA Licensed

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS with comprehensive CNV analysis.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance by a DHA-licensed Consultant Medical Geneticist for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Ataxia Comprehensive Panel by Next‑Generation Sequencing (NGS) is specifically designed for patients in the UAE presenting with progressive imbalance, slurred speech, and coordination difficulties. This genetic test identifies the precise hereditary cause and guides clinical management, enabling early intervention and family screening.

Feature	Our Test (DHA-Aligned)	Closest Alternative (Limited Panel)
Precision (Analytical Sensitivity)	99.9% for single nucleotide variants & CNVs	~97% (targeted exome only, no CNV)
Methodology	Massively Parallel Sequencing (NGS) with CNV detection	Sanger sequencing of a few repeat expansions
Turnaround Time	3–4 Weeks (ISO Cold Chain)	6–8 Weeks (conventional logistics)

Physician Insight & Safety Protocols

“As a DHA-licensed Consultant Medical Geneticist, I emphasize that a positive result on this panel is a starting point—not a final diagnosis. Clinical correlation with neurological examination, family history, and neuroimaging is essential to differentiate hereditary ataxias from acquired conditions. Please consult your specialist before any therapeutic decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

🛑 Medication Advisory

Do not discontinue any prescribed medication (e.g., antiepileptics, immunomodulators) without direct consultation with your treating physician. Abrupt changes may worsen underlying neurological symptoms.

Safety Exclusion Criteria & Emergency Red Flags

Not suitable for patients with acute stroke, active CNS infection, or traumatic brain injury within 6 weeks.
A recent (≤3 days) blood transfusion may invalidate germline genetic testing.
Seek emergency care if you develop sudden severe headache, vision loss, inability to swallow, or respiratory distress – these are not explained by a genetic panel and require immediate evaluation.

Patient FAQ & Clinical Guidance

1. How does the Ataxia Comprehensive Panel differ from a regular MRI for balance problems?

A brain MRI reveals structural changes (e.g., cerebellar atrophy), while this genetic panel identifies the underlying hereditary cause at the DNA level, enabling precise family screening and prognostic counseling.

2. Is the test painful and can it be performed at home in Dubai?

Only a standard blood draw is required. Our VIP mobile phlebotomy team visits your home, hotel, or office between 8 AM and 11 PM with strict cold‑chain transport and ISO-certified handling protocols.

3. How are results delivered and interpreted?

Results are reported within 3‑4 weeks and include a detailed molecular report. A complimentary telephonic consultation with a DHA-licensed medical geneticist is provided to discuss findings and next steps.

UAE Regulatory & Data Privacy Adherence

This test operates under the direct licensure of Dubai Health Authority (DHA Facility License No. 1143) and complies fully with:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring secure handling of genetic information.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing electronic health records and telemedicine.
Federal Decree-Law No. 4 of 2016 on Medical Liability – upholding patient safety and informed consent for genetic testing.

All blood samples are processed in our CAP-accredited laboratory, and results are reported under strict confidentiality protocols.

Clinical & Logistical Metadata

Test Name	Ataxia Comprehensive Panel (Genetic Test)
Price (AED)	3,000 AED
Turnaround Time	3–4 Weeks (ISO Cold Chain Logistics)
Sample Type / Matrix	Peripheral whole blood (3–5 mL in EDTA tube)
Methodology Used	Massively Parallel Sequencing (NGS) with CNV analysis
ICD-10-CM Code	G11.9 (Hereditary ataxia, unspecified)
LOINC Code	81247-9 (Ataxia panel)
DHA Facility License & Laboratory Address	License #1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE